Gilbert Halley E 4
4 · Vaxcyte, Inc. · Filed Jun 5, 2024
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Gilbert Halley E
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-06-03−18,200→ 30,374 totalExercise: $5.35Exp: 2030-04-17→ Common Stock (18,200 underlying) - Exercise/Conversion
Common Stock
2024-06-03$5.35/sh+18,200$97,370→ 23,825 total - Sale
Common Stock
2024-06-03$73.00/sh−18,200$1,328,600→ 5,625 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024.
- [F2]Option is fully vested and exercisable.
- [F3]Reporting Person has transferred 30,374 vested stock options to Reporting Person's ex-spouse pursuant to a "domestic relations order" as defined in Section 16(a)(12) of the Securities Exchange Act of 1934, as amended. Accordingly, Reporting Person will not report beneficial ownership of or dispositions or acquisitions of the underlying shares in future Section 16(a) filings.